Search results for "Inflammatory bowel disease"
Continuing anti-TNF therapy in pregnancy appears beneficial for patients with IBD
A French target trial emulation, which refers to the use of observational data to mimic a randomized controlled trial, found that maternal relapse of inflammatory bowel disease (IBD) and premature births were less common when patients continued anti-tumor necrosis factor (anti-TNF) therapy after 24 weeks of pregnancy than when the drugs were discontinued.
https://gastroenterology.acponline.org/archives/2022/10/28/8.htm
28 Oct 2022
In active UC, upadacitinib induced and maintained remission
JAK inhibitors, such as upadacitinib, represent an advance in the management of patients with ulcerative colitis (UC); however, it remains unclear whether the balance of efficacy versus risk favors one drug over the others, according to an ACP Journal Club commentary.
https://gastroenterology.acponline.org/archives/2022/10/28/11.htm
28 Oct 2022
MKSAP Quiz: Follow-up after a diagnosis of primary sclerosing cholangitis
This month's quiz asks readers to determine the most appropriate management of a 34-year-old patient who presents to follow-up after receiving a diagnosis of primary sclerosing cholangitis.
https://gastroenterology.acponline.org/archives/2022/11/18/4.htm
18 Nov 2022
Healthy lifestyle may mitigate genetic risk for inflammatory bowel disease
In a cohort study, U.K. residents with high genetic risk for inflammatory bowel disease who met four or five lifestyle measures developed Crohn's disease or ulcerative colitis at higher-than-average rates, but at about half the rate of those with both genetic risk and an unhealthy lifestyle.
https://gastroenterology.acponline.org/archives/2023/01/27/3.htm
27 Jan 2023
Review finds only two efficacious medications to treat gastroparesis
Clebopride ranked first for efficacy, followed by domperidone, and no other drug was superior to placebo for improving symptoms of gastroparesis, according to a recent meta-analysis.
https://gastroenterology.acponline.org/archives/2023/01/27/2.htm
27 Jan 2023
Spotlight on the cost of gastroenteritis
Two industry-funded studies looked at the economic burden of acute infectious gastroenteritis among U.S. adults and found that use of large multiplex polymerase chain reaction panels was associated with similar costs as traditional workup.
https://gastroenterology.acponline.org/archives/2023/02/24/5.htm
24 Feb 2023
Colonoscopy common, riskier in those with life expectancy of less than 10 years
A study of patients undergoing screening colonoscopy after age 75 years found that relatively few cancers were found and treated and that the risk of adverse events requiring hospitalization was high and rose with age.
https://gastroenterology.acponline.org/archives/2023/04/21/1.htm
21 Apr 2023
IBD increases long-term stroke risk, study finds
A Swedish study found that patients with inflammatory bowel disease (IBD) were at higher risk for incident stroke, especially ischemic stroke, versus matched controls and versus their siblings for up to 25 years.
https://gastroenterology.acponline.org/archives/2023/06/23/3.htm
23 Jun 2023
Spotlight on abdominal bloating
Bloating is common throughout the world, is strongly associated with abdominal pain, and may improve with adequate doses of rifaximin, recent studies found.
https://gastroenterology.acponline.org/archives/2023/06/23/5.htm
23 Jun 2023
IBD patients may be at higher risk for CKD
A Swedish study found that 11.8% of patients with inflammatory bowel disease (IBD) were diagnosed with chronic kidney disease (CKD) within 10 years, and their risks of acute kidney injury and kidney stones were also elevated.
https://gastroenterology.acponline.org/archives/2023/08/25/2.htm
25 Aug 2023